Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -26.317% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) COC(=O)c1cccc(NC(=O)CN2CCC(NC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)c1
b.) COc1cc(S(=O)(=O)N2CCN(C(=O)c3ccccc3)CC2)c(OC)cc1Br
c.) O=CN1CCC(=O)N(Cc2ccccc2)c2ccccc21
d.) CCN(CC)Cc1c(C(=O)N/N=C/c2ccc(C)o2)nnn1-c1nonc1N
e.) Oc1ccccc1/C=N/NC(=S)NC1CC2CCC1C2
Answer: d. CCN(CC)Cc1c(C(=O)N/N=C/c2ccc(C)o2)nnn1-c1nonc1N
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)Cc1c(C(=O)N/N=C/c2ccc(C)o2)nnn1-c1nonc1N
CCN(CC)Cc1c(C(=O)N/N=C/c2ccc(C)o2)nnn1-c1nonc1N
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-(diethylaminomethyl)-N-[(E)-(5-methylfuran-2-yl)methylideneamino]triazole-4-carboxamide